Correlation Between Lipella Pharmaceuticals and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lipella Pharmaceuticals and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipella Pharmaceuticals and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipella Pharmaceuticals Common and Foghorn Therapeutics, you can compare the effects of market volatilities on Lipella Pharmaceuticals and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipella Pharmaceuticals with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipella Pharmaceuticals and Foghorn Therapeutics.
Diversification Opportunities for Lipella Pharmaceuticals and Foghorn Therapeutics
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Lipella and Foghorn is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Lipella Pharmaceuticals Common and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and Lipella Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipella Pharmaceuticals Common are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of Lipella Pharmaceuticals i.e., Lipella Pharmaceuticals and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between Lipella Pharmaceuticals and Foghorn Therapeutics
Given the investment horizon of 90 days Lipella Pharmaceuticals Common is expected to generate 3.63 times more return on investment than Foghorn Therapeutics. However, Lipella Pharmaceuticals is 3.63 times more volatile than Foghorn Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Foghorn Therapeutics is currently generating about 0.31 per unit of risk. If you would invest 285.00 in Lipella Pharmaceuticals Common on November 18, 2024 and sell it today you would earn a total of 103.00 from holding Lipella Pharmaceuticals Common or generate 36.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lipella Pharmaceuticals Common vs. Foghorn Therapeutics
Performance |
| Timeline |
| Lipella Pharmaceuticals |
| Foghorn Therapeutics |
Lipella Pharmaceuticals and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipella Pharmaceuticals and Foghorn Therapeutics
The main advantage of trading using opposite Lipella Pharmaceuticals and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipella Pharmaceuticals position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
| Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |